Fulton Bank N.A. boosted its holdings in shares of The Procter & Gamble Company (NYSE:PG – Free Report) by 1.3% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 27,630 shares of the company’s stock after buying an additional 366 shares during the period. Fulton Bank N.A.’s holdings in Procter & Gamble were worth $4,632,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Acorn Creek Capital LLC boosted its position in shares of Procter & Gamble by 2.8% in the 3rd quarter. Acorn Creek Capital LLC now owns 2,170 shares of the company’s stock worth $376,000 after purchasing an additional 59 shares in the last quarter. Patrick M Sweeney & Associates Inc. raised its holdings in Procter & Gamble by 1.1% in the 3rd quarter. Patrick M Sweeney & Associates Inc. now owns 5,561 shares of the company’s stock worth $963,000 after acquiring an additional 59 shares during the last quarter. Traveka Wealth LLC lifted its position in Procter & Gamble by 1.7% in the 3rd quarter. Traveka Wealth LLC now owns 3,554 shares of the company’s stock valued at $616,000 after acquiring an additional 60 shares in the last quarter. Allen Mooney & Barnes Investment Advisors LLC boosted its stake in Procter & Gamble by 0.7% during the 3rd quarter. Allen Mooney & Barnes Investment Advisors LLC now owns 8,699 shares of the company’s stock valued at $1,507,000 after purchasing an additional 61 shares during the last quarter. Finally, Valued Wealth Advisors LLC increased its holdings in shares of Procter & Gamble by 11.2% in the 3rd quarter. Valued Wealth Advisors LLC now owns 605 shares of the company’s stock worth $105,000 after purchasing an additional 61 shares in the last quarter. Institutional investors own 65.77% of the company’s stock.
Wall Street Analysts Forecast Growth
Several research firms have issued reports on PG. Hsbc Global Res upgraded shares of Procter & Gamble to a “strong-buy” rating in a research note on Friday, October 4th. Piper Sandler started coverage on Procter & Gamble in a report on Tuesday, September 24th. They set a “neutral” rating and a $174.00 price target on the stock. Wells Fargo & Company cut their price objective on Procter & Gamble from $190.00 to $176.00 and set an “overweight” rating for the company in a report on Tuesday. Royal Bank of Canada reissued a “sector perform” rating and issued a $164.00 target price on shares of Procter & Gamble in a report on Monday, October 21st. Finally, Morgan Stanley boosted their price target on Procter & Gamble from $174.00 to $191.00 and gave the company an “overweight” rating in a research note on Monday, October 21st. Eight investment analysts have rated the stock with a hold rating, fourteen have issued a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat.com, Procter & Gamble has an average rating of “Moderate Buy” and an average price target of $179.75.
Insider Buying and Selling
In other Procter & Gamble news, CEO Gary A. Coombe sold 47,847 shares of the company’s stock in a transaction dated Wednesday, November 27th. The shares were sold at an average price of $179.84, for a total value of $8,604,804.48. Following the transaction, the chief executive officer now directly owns 39,977 shares in the company, valued at $7,189,463.68. This represents a 54.48 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Balaji Purushothaman sold 12,800 shares of the stock in a transaction that occurred on Thursday, October 24th. The stock was sold at an average price of $168.99, for a total value of $2,163,072.00. Following the completion of the transaction, the insider now directly owns 11,566 shares in the company, valued at approximately $1,954,538.34. This trade represents a 52.53 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 75,439 shares of company stock valued at $13,317,460 in the last ninety days. 0.18% of the stock is owned by company insiders.
Procter & Gamble Price Performance
PG traded up $0.31 during trading hours on Wednesday, hitting $161.61. The company’s stock had a trading volume of 1,797,333 shares, compared to its average volume of 5,912,134. The Procter & Gamble Company has a 12 month low of $146.28 and a 12 month high of $180.43. The stock has a market cap of $380.60 billion, a price-to-earnings ratio of 27.86, a P/E/G ratio of 3.70 and a beta of 0.45. The business’s 50-day moving average price is $169.92 and its 200-day moving average price is $169.75. The company has a current ratio of 0.75, a quick ratio of 0.55 and a debt-to-equity ratio of 0.50.
Procter & Gamble (NYSE:PG – Get Free Report) last issued its quarterly earnings data on Friday, October 18th. The company reported $1.93 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.90 by $0.03. The business had revenue of $21.74 billion for the quarter, compared to the consensus estimate of $21.99 billion. Procter & Gamble had a return on equity of 33.25% and a net margin of 17.07%. The company’s quarterly revenue was down .6% compared to the same quarter last year. During the same period in the prior year, the business posted $1.83 earnings per share. Sell-side analysts expect that The Procter & Gamble Company will post 6.94 earnings per share for the current fiscal year.
About Procter & Gamble
The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.
Read More
- Five stocks we like better than Procter & Gamble
- How to Use the MarketBeat Stock Screener
- Moderna Shares Spike on H5N1 News—What’s Next for Investors?
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- Nebius Group (NBIS): A Small-Cap Backed by NVIDIA
- How to Invest in Small Cap Stocks
- Natural Gas Demand to Surge: Top 3 Stocks and ETFs to Consider
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.